H-1337 Ophthalmic Solution Phase 1/2

Clinical trial NCT03452033 · COMPLETED

Trial details

NCT number: NCT03452033
Sponsor: Allysta Pharmaceutical
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glaucoma, Open-Angle

Start date: 2018-03-15
Primary completion: 2018-08-15
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.